1. Home
  2. GPUS vs ONCO Comparison

GPUS vs ONCO Comparison

Compare GPUS & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • ONCO
  • Stock Information
  • Founded
  • GPUS 1969
  • ONCO 2018
  • Country
  • GPUS United States
  • ONCO United States
  • Employees
  • GPUS 643
  • ONCO N/A
  • Industry
  • GPUS
  • ONCO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • ONCO Health Care
  • Exchange
  • GPUS NYSE
  • ONCO Nasdaq
  • Market Cap
  • GPUS 4.2M
  • ONCO 9.4M
  • IPO Year
  • GPUS 1996
  • ONCO 2022
  • Fundamental
  • Price
  • GPUS $3.69
  • ONCO $0.61
  • Analyst Decision
  • GPUS
  • ONCO
  • Analyst Count
  • GPUS 0
  • ONCO 0
  • Target Price
  • GPUS N/A
  • ONCO N/A
  • AVG Volume (30 Days)
  • GPUS 79.7K
  • ONCO 10.5M
  • Earning Date
  • GPUS 11-19-2024
  • ONCO 12-10-2024
  • Dividend Yield
  • GPUS N/A
  • ONCO N/A
  • EPS Growth
  • GPUS N/A
  • ONCO N/A
  • EPS
  • GPUS N/A
  • ONCO N/A
  • Revenue
  • GPUS $139,425,000.00
  • ONCO $1,870,605.00
  • Revenue This Year
  • GPUS N/A
  • ONCO N/A
  • Revenue Next Year
  • GPUS N/A
  • ONCO N/A
  • P/E Ratio
  • GPUS N/A
  • ONCO N/A
  • Revenue Growth
  • GPUS 3.50
  • ONCO N/A
  • 52 Week Low
  • GPUS $3.09
  • ONCO $0.32
  • 52 Week High
  • GPUS $35.89
  • ONCO $21.40
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • ONCO 51.04
  • Support Level
  • GPUS N/A
  • ONCO $0.51
  • Resistance Level
  • GPUS N/A
  • ONCO $0.70
  • Average True Range (ATR)
  • GPUS 0.00
  • ONCO 0.09
  • MACD
  • GPUS 0.00
  • ONCO 0.03
  • Stochastic Oscillator
  • GPUS 0.00
  • ONCO 34.45

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: